DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $213,246 | +22.5% | 853,496 | +22.4% | 0.71% | +24.5% |
Q1 2024 | $174,073 | +35.6% | 697,071 | +25.6% | 0.57% | +24.1% |
Q4 2023 | $128,375 | -0.0% | 554,919 | +7.2% | 0.46% | -4.2% |
Q3 2023 | $128,376 | +3.4% | 517,436 | 0.0% | 0.48% | +12.4% |
Q2 2023 | $124,185 | +108.3% | 517,436 | +118.8% | 0.43% | +99.1% |
Q1 2023 | $59,615 | -33.3% | 236,531 | -29.7% | 0.22% | -32.8% |
Q4 2022 | $89,321 | -99.9% | 336,527 | +32.3% | 0.32% | +33.3% |
Q3 2022 | $65,692,000 | +14.4% | 254,336 | +12.3% | 0.24% | +18.2% |
Q2 2022 | $57,425,000 | -57.4% | 226,511 | -50.7% | 0.20% | -43.5% |
Q1 2022 | $134,819,000 | +109.8% | 459,616 | +135.3% | 0.36% | +145.9% |
Q4 2021 | $64,268,000 | +6.4% | 195,338 | -1.6% | 0.15% | +0.7% |
Q3 2021 | $60,425,000 | -6.0% | 198,477 | -17.1% | 0.14% | -6.5% |
Q2 2021 | $64,253,000 | -33.1% | 239,427 | -43.9% | 0.16% | -36.7% |
Q1 2021 | $96,109,000 | -19.6% | 427,000 | -20.7% | 0.24% | -22.5% |
Q4 2020 | $119,553,000 | -1.2% | 538,189 | -4.2% | 0.32% | -18.1% |
Q3 2020 | $120,959,000 | +18.5% | 561,737 | -2.7% | 0.39% | +8.1% |
Q2 2020 | $102,069,000 | +58.0% | 577,212 | +23.7% | 0.36% | +24.8% |
Q1 2020 | $64,595,000 | +102.5% | 466,696 | +124.6% | 0.29% | +169.8% |
Q4 2019 | $31,891,000 | -20.3% | 207,784 | -25.0% | 0.11% | -22.1% |
Q3 2019 | $39,998,000 | +31.6% | 276,939 | +30.2% | 0.14% | +37.4% |
Q2 2019 | $30,398,000 | +457.5% | 212,690 | +262.3% | 0.10% | +518.8% |
Q4 2015 | $5,453,000 | -13.9% | 58,707 | -28.5% | 0.02% | +14.3% |
Q4 2013 | $6,337,000 | – | 82,081 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |